Tag Archives: Brexit

Guidance for UK Life Sciences Offered During End of Brexit Transition

With the Brexit transition period ending on December 31st, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is issuing guidance for the UK Life Science industry – including guidance on clinical trials, market authorizations, and manufacture and supply, among other areas. The guidance will apply from the start of 2021. Squire Patton Boggs’ Triage … Continue Reading

Webinar: Deciphering and Maximizing Key Benefits of the European Trademark System and the Fallout from Brexit

Our Intellectual Property & Technology Practice partner Deborah Lodge (Washington) will be speaking in a Clear Law Institute webinar on the European Trademark system and Brexit’s impact on trademark rights – Deciphering and Maximizing Key Benefits of the European Trademark System and the Fallout from Brexit scheduled for June 21, 2017 at 1:00 to 2:15 pm … Continue Reading
LexBlog